drugset / Trial / NCT03266900
A Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival
Phase 0
Terminated
2 enrolled
University Health Network, Toronto
Bladder Cancer Canada · collabCanadian Urologic Oncology Group · collabCanadian Urological Association · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The investigators would like to compare the progression free survival, overall survival, quality of life, and safety outcomes of patients receiving versus not receiving a 2nd transurethral resection of bladder tumor.
Timeline
- Start
- 2017-11-16
- Primary completion
- 2021-10-04
- Completion
- 2021-10-04
Outcome
Outcome not reported
Stopped (Enrollment): “Difficulties with accrual”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | BCG | Unknown | — | — |